rs747798210

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_003036.4(SKI):​c.2174A>C​(p.Glu725Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000374 in 1,522,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E725D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000022 ( 0 hom. )

Consequence

SKI
NM_003036.4 missense

Scores

2
2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.210

Publications

0 publications found
Variant links:
Genes affected
SKI (HGNC:10896): (SKI proto-oncogene) This gene encodes the nuclear protooncogene protein homolog of avian sarcoma viral (v-ski) oncogene. It functions as a repressor of TGF-beta signaling, and may play a role in neural tube development and muscle differentiation. [provided by RefSeq, Oct 2009]
SKI Gene-Disease associations (from GenCC):
  • Shprintzen-Goldberg syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, PanelApp Australia, G2P, Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.048023462).
BP6
Variant 1-2306752-A-C is Benign according to our data. Variant chr1-2306752-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 213700.
BS2
High AC in GnomAd4 at 27 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SKINM_003036.4 linkc.2174A>C p.Glu725Ala missense_variant Exon 7 of 7 ENST00000378536.5 NP_003027.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SKIENST00000378536.5 linkc.2174A>C p.Glu725Ala missense_variant Exon 7 of 7 1 NM_003036.4 ENSP00000367797.4

Frequencies

GnomAD3 genomes
AF:
0.000178
AC:
27
AN:
152000
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
116978
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000219
AC:
30
AN:
1370082
Hom.:
0
Cov.:
32
AF XY:
0.0000222
AC XY:
15
AN XY:
675516
show subpopulations
African (AFR)
AF:
0.000769
AC:
22
AN:
28604
American (AMR)
AF:
0.00
AC:
0
AN:
33748
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24260
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33536
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77042
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41988
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4070
European-Non Finnish (NFE)
AF:
9.34e-7
AC:
1
AN:
1070118
Other (OTH)
AF:
0.000123
AC:
7
AN:
56716
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.435
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000178
AC:
27
AN:
152110
Hom.:
0
Cov.:
33
AF XY:
0.000148
AC XY:
11
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.000650
AC:
27
AN:
41548
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5140
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10568
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67964
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000162
ExAC
AF:
0.0000528
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
Jul 31, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.E725A variant (also known as c.2174A>C), located in coding exon 7 of the SKI gene, results from an A to C substitution at nucleotide position 2174. The glutamic acid at codon 725 is replaced by alanine, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -

not provided Uncertain:1
May 08, 2019
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Reported in ClinVar but additional evidence is not available (ClinVar Variant ID# 213700; Landrum et al., 2016) -

Shprintzen-Goldberg syndrome Benign:1
Jan 14, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
13
DANN
Benign
0.92
DEOGEN2
Benign
0.26
T
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.43
FATHMM_MKL
Benign
0.24
N
LIST_S2
Benign
0.55
T
M_CAP
Pathogenic
0.93
D
MetaRNN
Benign
0.048
T
MetaSVM
Uncertain
-0.17
T
MutationAssessor
Benign
1.8
L
PhyloP100
0.21
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-1.0
N
REVEL
Uncertain
0.35
Sift
Benign
0.044
D
Sift4G
Benign
0.39
T
Polyphen
0.075
B
Vest4
0.19
MutPred
0.20
Loss of solvent accessibility (P = 0.0769);
MVP
0.64
MPC
1.2
ClinPred
0.18
T
GERP RS
4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.059
gMVP
0.18
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747798210; hg19: chr1-2238191; API